GLP-1 Monthly Budget Guide: The True Cost of Weight Loss Treatment
The sticker price of GLP-1 medication is not the whole story. When you factor in food savings, health cost reductions, and tax benefits, the true monthly cost may surprise you.
The question "Can I afford GLP-1 medication?" is the wrong question. The right question is "What is the net cost after accounting for all the financial changes that come with treatment?" For many patients taking semaglutide or tirzepatide, the medication nearly pays for itself through reduced food spending alone.
Disclaimer
Financial figures are estimates based on averages. Your actual costs and savings will vary based on individual circumstances.
Direct Monthly Costs
Monthly Cost Breakdown
| Expense | Semaglutide | Tirzepatide |
|---|---|---|
| Medication (Trimi) | $125 | $125 |
| Provider consultation | Included | Included |
| Injection supplies | $5-$10 | $5-$10 |
| Protein supplement (optional) | $20-$40 | $20-$40 |
| Lab work (amortized) | $5-$15 | $5-$15 |
| Total Direct Cost | $129-$164 | $155-$190 |
Monthly Savings on GLP-1 Treatment
Typical Monthly Savings
| Savings Source | Monthly Savings |
|---|---|
| Reduced grocery spending | $75-$200 |
| Fewer restaurant meals | $50-$150 |
| Reduced snack/convenience food | $30-$75 |
| No alcohol (many patients stop) | $0-$100 |
| HSA/FSA tax savings | $25-$50 |
| Reduced other medication costs | $0-$100 |
| Total Savings | $180-$675 |
Calculating Your Net Monthly Cost
For many Trimi patients, the net monthly cost of GLP-1 treatment is effectively zero or even negative. Take a conservative estimate: $140 in direct costs minus $180 in food and tax savings equals negative $40. You are actually saving money while getting medical treatment that improves your health and quality of life.
Track your food spending for a month before starting medication, then compare it to your spending two to three months into treatment. Most patients are genuinely surprised by how much less they spend when appetite is properly regulated.
Budget-Friendly Approaches
Tight Budget ($100-$130/mo)
Choose compounded semaglutide at $99/mo through Trimi. Skip optional supplements and focus on getting protein from affordable whole foods (eggs, chicken thighs, Greek yogurt, canned tuna). Use a free app for food tracking instead of paid services. Do bodyweight exercises at home instead of a gym membership.
Moderate Budget ($150-$200/mo)
Choose semaglutide or tirzepatide based on your clinical needs. Add a quality protein powder ($30/mo) for convenient post-workout nutrition. Consider a basic gym membership or online fitness subscription. Pay through your HSA or FSA for pre-tax savings.
Flexible Budget ($200+/mo)
Choose tirzepatide for maximum efficacy. Add protein supplements, a gym membership, and periodic lab monitoring. Consider adding therapy for psychological support. Invest in meal prep services or quality meal delivery to optimize nutrition.
Smart Payment Strategies
Use HSA or FSA funds for pre-tax payment. Set up automatic billing to avoid missed doses. Track all expenses for potential tax deductions. Redirect your food savings into a dedicated health account. And explore whether your employer offers wellness stipends that could offset costs.
The Bottom Line
GLP-1 treatment from Trimi costs less than most people spend on daily coffee. When you factor in the food savings, tax benefits, and long-term health cost reductions, the net cost is often zero or negative. Do not let sticker shock prevent you from exploring a treatment that could transform your health and potentially save you money.
Affordable Treatment That Pays for Itself
Semaglutide $99/mo. Tirzepatide $125/mo. No hidden fees.
View PricingMore on financial strategies
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).